Why do we need a selective angiotensin II type 2 receptor agonist?

Hypertension

Volumn 60, Issue 3, 2012, Pages 616-617

  Henrion, Daniel ^a,b,c  

^a UNIVERSITÉ D'ANGERS   (France)

^b CNRS   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; COMPOUND 21; UNCLASSIFIED DRUG;

CELL PROLIFERATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; HEART MUSCLE FIBROSIS; HUMAN; INFLAMMATION; NONHUMAN; NOTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASOCONSTRICTION; VASODILATATION;

ANIMALS; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; ILIAC ARTERY; MALE; MESENTERIC ARTERIES; RECEPTOR, ANGIOTENSIN, TYPE 2; VASODILATION;

EID: 84865499511     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.197046     Document Type: Note

References (10)

1. Steckelings UM, Larhed M, Hallberg A, Widdop RE, Jones ES, Wallinder C, Namsolleck P, Dahlof B, Unger T. Non-peptide AT2-receptor agonists. Curr Opin Pharmacol. 2011;11:187-192.
2. Savoia C, Tabet F, Yao G, Schiffrin EL, Touyz RM. Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats. J Hypertens. 2005;23:1037-1045.
3. Stergiou GS, Skeva II. Renin-angiotensin system blockade at the level of the angiotensin converting enzyme or the angiotensin type-1 receptor: similarities and differences. Curr Top Med Chem. 2004;4:473-481.
4. Jones ES, Vinh A, McCarthy CA, Gaspari TA, Widdop RE. AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther. 2008;120:292-316.
5. Verdonk K, Durik M, Abd-Alla N, Batenburg WW, van den Bogaerdt AJ, van Veghel R, Roks AJM, Danser AHJ, van Esch JHM. Compound 21 induces vasorelaxation via an endothelium-and angiotensin II type 2 receptor-independent mechanism. Hypertension. 2012;60:722-729.
6. Matrougui K, Levy BI, Henrion D. Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats. Br J Pharmacol. 2000;130:521-526.
7. Pinaud F, Bocquet A, Dumont O, Retailleau K, Baufreton C, Andriantsitohaina R, Loufrani L, Henrion D. Paradoxical role of angiotensin II type 2 receptors in resistance arteries of old rats. Hypertension. 2007;50: 96-102.
8. Hilliard LM, Nematbakhsh M, Kett MM, Teichman E, Sampson AK, Widdop RE, Evans RG, Denton KM. Gender differences in pressurenatriuresis and renal autoregulation: role of the Angiotensin type 2 receptor. Hypertension. 2011;57:275-282.
9. Widdop RE, Matrougui K, Levy BI, Henrion D. AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade. Hypertension. 2002;40:516-520.
10. Gwathmey TM, Alzayadneh EM, Pendergrass KD, Chappell MC. Novel roles of nuclear angiotensin receptors and signaling mechanisms. Am J Physiol. 2012;302:R518-R530.